Bartter, Gitelman, Liddle & Gordon

TL;DR

Eponyms: Bartter, Gitelman, Liddle, Gordon are among the highest-yield inherited renal tubular disorders tested in MRCP Part 1 because they combine physiology, electrolyte interpretation and pharmacology in one topic. Remember the characteristic blood pressure, potassium, acid–base status, renin–aldosterone profile and site of tubular defect. A simple comparison framework makes these conditions far easier to recognise in exam questions than memorising isolated facts.

Why this matters

These four syndromes represent abnormalities affecting different segments of the nephron:

• Thick ascending limb (Bartter)

• Distal convoluted tubule (Gitelman)

• Collecting duct ENaC channel (Liddle)

• Distal nephron sodium chloride transporter regulation (Gordon)

MRCP questions frequently ask candidates to:

• Identify the diagnosis from electrolyte abnormalities.

• Predict renin and aldosterone levels.

• Choose the most appropriate treatment.

• Identify the affected transporter.

• Distinguish inherited disorders from diuretic use or endocrine disease.

Core sections

1. High-yield comparison table

Feature	Bartter	Gitelman	Liddle	Gordon
Main defect	NKCC2 transporter	NCC transporter	ENaC overactivity	WNK pathway mutation
Site	Thick ascending limb	Distal convoluted tubule	Collecting duct	Distal nephron
Blood pressure	Normal or low	Normal or low	High	High
Potassium	Low	Low	Low	High
Acid-base	Metabolic alkalosis	Metabolic alkalosis	Metabolic alkalosis	Metabolic acidosis
Magnesium	Usually normal	Low	Normal	Normal
Urinary calcium	High	Low	Normal	Variable
Renin	High	High	Low	Low
Aldosterone	High	High	Low	Low
Treatment	NSAIDs ± potassium	Magnesium replacement	Amiloride	Thiazide

This single table covers most examination questions on these syndromes.

2. The five most tested subtopics

A. Site of nephron involvement

Knowing the nephron segment often allows you to answer multiple questions.

Bartter syndrome

• Thick ascending limb

• Defective NKCC2 transporter

• Mimics chronic loop diuretic therapy

Gitelman syndrome

• Distal convoluted tubule

• Defective sodium-chloride cotransporter

• Mimics chronic thiazide use

Liddle syndrome

• Collecting duct

• Increased epithelial sodium channel (ENaC) activity

• Sodium retention despite low aldosterone

Gordon syndrome

• Increased sodium chloride reabsorption in distal nephron

• WNK kinase mutations

• Hyperkalaemic hypertension

B. Blood pressure patterns

A favourite examination discriminator.

Normal or low blood pressure:

• Bartter

• Gitelman

Hypertension:

• Liddle

• Gordon

Whenever hypertension accompanies hypokalaemia with suppressed renin and aldosterone, think Liddle syndrome before primary hyperaldosteronism.

C. Potassium and acid-base abnormalities

Bartter

• Hypokalaemia

• Metabolic alkalosis

Gitelman

• Hypokalaemia

• Metabolic alkalosis

• Often symptomatic due to hypomagnesaemia

Liddle

• Hypokalaemia

• Metabolic alkalosis

• Low renin and aldosterone

Gordon

• Hyperkalaemia

• Hyperchloraemic metabolic acidosis

Gordon syndrome is essentially the "opposite" biochemical pattern to Bartter and Gitelman.

D. Renin and aldosterone physiology

Understanding physiology is more reliable than memorisation.

Bartter and Gitelman

Salt wasting causes:

• Reduced intravascular volume

• Increased renin

• Increased aldosterone

Liddle

Primary sodium retention suppresses:

• Renin

• Aldosterone

Gordon

Volume expansion similarly suppresses:

• Renin

• Aldosterone

E. Treatment principles

Treatment often appears as the final step in SBA questions.

Bartter

• Potassium supplementation

• NSAIDs (reduce prostaglandin production)

• Occasionally ACE inhibitors

Gitelman

• Oral magnesium replacement

• Potassium supplementation

Liddle

• Amiloride or triamterene

• Spironolactone is ineffective because aldosterone is already suppressed

Gordon

• Low-dose thiazide diuretics

• Excellent response is characteristic

For further electrolyte revision, see our related article on Acid-base disorders for MRCP Part 1.

3. Ten high-yield examination points

1. Bartter resembles loop diuretic use.

2. Gitelman resembles thiazide use.

3. Gitelman causes hypomagnesaemia.

4. Bartter causes hypercalciuria.

5. Gitelman causes hypocalciuria.

6. Liddle causes hypertension despite low aldosterone.

7. Gordon causes hyperkalaemic hypertension.

8. Amiloride treats Liddle syndrome.

9. Thiazides treat Gordon syndrome.

10. Renin and aldosterone are elevated in Bartter and Gitelman but suppressed in Liddle and Gordon.

4. Five classic examination traps

Trap 1

Confusing Bartter with Gitelman.

Remember:

• Bartter → calcium lost

• Gitelman → calcium retained

Trap 2

Using spironolactone for Liddle syndrome.

Because aldosterone is already low, spironolactone has little effect.

Trap 3

Missing hypomagnesaemia.

Persistent muscle cramps or tetany strongly suggest Gitelman syndrome.

Trap 4

Thinking all hypokalaemia indicates hyperaldosteronism.

Liddle syndrome produces identical potassium abnormalities but suppressed aldosterone.

Trap 5

Ignoring blood pressure.

This single clue often separates the syndromes immediately.

Practical examples / mini-cases

Mini-case

A 24-year-old woman presents with fatigue and muscle cramps. Blood tests show:

• Potassium 2.8 mmol/L

• Magnesium 0.45 mmol/L

• Metabolic alkalosis

• Normal blood pressure

• Low urinary calcium

Most likely diagnosis?

Answer: Gitelman syndrome.

Explanation

Hypomagnesaemia together with hypocalciuria is highly characteristic of Gitelman syndrome and differentiates it from Bartter syndrome.

Practical study-tip checklist

Before the examination, ensure you can answer the following without hesitation:

• □ Identify the nephron site.

• □ Know the transporter involved.

• □ Predict blood pressure.

• □ Predict potassium level.

• □ Predict acid-base abnormality.

• □ Predict calcium excretion.

• □ Predict magnesium level.

• □ Predict renin.

• □ Predict aldosterone.

• □ Recall first-line treatment.

If you can complete this checklist from memory, you are well prepared for almost every MRCP Part 1 question on inherited tubulopathies.

For regular practice, revise these disorders using the Free MRCP MCQs and consolidate knowledge with the MRCP Part 1 lectures.

Common pitfalls

• Forgetting that Bartter resembles loop diuretics whereas Gitelman resembles thiazides.

• Mixing up urinary calcium findings between Bartter and Gitelman.

• Prescribing spironolactone instead of amiloride for Liddle syndrome.

• Forgetting Gordon syndrome presents with hyperkalaemia rather than hypokalaemia.

• Ignoring blood pressure when differentiating these conditions.

FAQs

Which syndrome is associated with hypomagnesaemia?

Gitelman syndrome is classically associated with hypomagnesaemia and hypocalciuria. These features help distinguish it from Bartter syndrome.

Why is amiloride used in Liddle syndrome?

Liddle syndrome results from increased ENaC activity rather than excess aldosterone. Amiloride directly blocks ENaC and is therefore the treatment of choice.

Which syndrome causes hyperkalaemic hypertension?

Gordon syndrome causes hypertension with hyperkalaemia and metabolic acidosis. It is effectively treated with thiazide diuretics.

How do Bartter and Gitelman differ?

Bartter affects the thick ascending limb and causes hypercalciuria, whereas Gitelman affects the distal convoluted tubule and causes hypocalciuria with hypomagnesaemia.

How are these syndromes commonly tested in MRCP Part 1?

Most questions present electrolyte abnormalities, blood pressure and acid–base findings, requiring candidates to identify the syndrome, affected transporter and appropriate treatment.

Ready to start?

Mastering renal physiology is one of the highest-yield strategies for MRCP Part 1 success. Continue your revision with the MRCP Part 1 overview, practise using the Free MRCP MCQs, strengthen concepts through the MRCP Part 1 lectures and test your progress with a mock test.

Sources

1. MRCP(UK). Examination syllabus and curriculum. https://www.mrcpuk.org/

2. KDIGO Clinical Practice Guidelines. https://kdigo.org/

3. Jameson JL, Fauci AS, Kasper DL, et al. Harrison's Principles of Internal Medicine.

4. Brenner & Rector's The Kidney.

5. National Institute for Health and Care Excellence (NICE). https://www.nice.org.uk/